Human natural fibroblast IFN-β, which belongs to the type I IFN family like IFN-α, is available for intravenous administration for the treatment of chronic hepatitis B and chronic hepatitis C in Japan. Here, IFNA1 is linked to chronic hepatitis C virus infection.